Clearmind Medicine Statistics
Total Valuation
CMND has a market cap or net worth of $5.44 million. The enterprise value is -$2.10 million.
Important Dates
The next estimated earnings date is Tuesday, December 3, 2024, before market open.
| Earnings Date | Dec 3, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
CMND has 4.06 million shares outstanding. The number of shares has increased by 1,696.41% in one year.
| Current Share Class | 4.06M |
| Shares Outstanding | 4.06M |
| Shares Change (YoY) | +1,696.41% |
| Shares Change (QoQ) | +9.42% |
| Owned by Insiders (%) | 0.96% |
| Owned by Institutions (%) | 9.04% |
| Float | 3.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.71, with a Debt / Equity ratio of 0.02.
| Current Ratio | 1.71 |
| Quick Ratio | 1.68 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -267.90% and return on invested capital (ROIC) is -115.35%.
| Return on Equity (ROE) | -267.90% |
| Return on Assets (ROA) | -57.95% |
| Return on Capital (ROIC) | -115.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.11M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CMND has paid $292,199 in taxes.
| Income Tax | 292,199 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.03% in the last 52 weeks. The beta is -1.52, so CMND's price volatility has been lower than the market average.
| Beta (5Y) | -1.52 |
| 52-Week Price Change | -63.03% |
| 50-Day Moving Average | 1.38 |
| 200-Day Moving Average | 1.35 |
| Relative Strength Index (RSI) | 43.86 |
| Average Volume (20 Days) | 116,745 |
Short Selling Information
The latest short interest is 316,596, so 7.80% of the outstanding shares have been sold short.
| Short Interest | 316,596 |
| Short Previous Month | 217,363 |
| Short % of Shares Out | 7.80% |
| Short % of Float | 9.85% |
| Short Ratio (days to cover) | 0.58 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.87M |
| Pretax Income | -6.68M |
| Net Income | -8.44M |
| EBITDA | -5.86M |
| EBIT | -5.87M |
| Earnings Per Share (EPS) | -$3.88 |
Full Income StatementBalance Sheet
The company has $7.68 million in cash and $60,898 in debt, giving a net cash position of $7.62 million or $1.88 per share.
| Cash & Cash Equivalents | 7.68M |
| Total Debt | 60,898 |
| Net Cash | 7.62M |
| Net Cash Per Share | $1.88 |
| Equity (Book Value) | 3.47M |
| Book Value Per Share | 0.87 |
| Working Capital | 3.32M |
Full Balance SheetCash Flow
| Operating Cash Flow | -4.53M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.53M |
| FCF Per Share | -$1.12 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |